4Nikpoor B, Turecki G, Fournier C, et al. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians[J]. Am Heart J, 2001,142(2) : 336-339.
5Chevrier I, Tregouet DA, Massonnet-Castel S, et al. Myeloper-oxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis[J]? Atherosclerosis, 2006,188(1) : 150-154.
6Cascorbi I, Henning S, Brockmoller J, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of themyeloperoxidase gene [J]. Cancer Res, 2000,60 ( 3 ) : 644-649.
7Puddu P,Cravero E, Evangelista V, et al . Genes and athero- sclerosis:at the origin of the predisposition[J]. Int J Clin Pract, 2005,59 (4) : 462-472.
8Austin GE, Lam L, Zaki SR, et al. Sequence comparison of putative regulatory DNA of the flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells[J]. Leukemia, 1993,7 (9) : 1445-1450.
9Sugiyama S, Okada Y, Sukhova GK, et al. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and impli cations in acute coronary syndromes[J]. Am J Pathol, 2001, 158(3) : 879-891.
10Sabatine MS,Morrow DA,Cannon CP,et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (treat angina with aggrastat and determine cost of therapy with an invasive or conservative strategythrombolysis in myocardial infarction 18 trial ) substudy[ J ]. J Am Coll Cardiol, 2002,40 (10) : 1761-1768.
